← All trials
NCT05470777
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 19, 2020
- Primary completion
- May 1, 2024
- Completion date
- Dec 31, 2024
- First posted
- Jul 22, 2022
- Last posted
- Nov 1, 2022
- Enrollment
- 35
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Soochow UniversityLead sponsor
- Nantong UniversityCollaborator
- Bengbu Medical CollegeCollaborator
- Jiangsu UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Suzhou Hospital of Traditional Chinese MedicineCollaborator
- Soochow UniversityReponsible party - principal investigator
- The Second People's Hospital of Huai'anCollaborator
- Soochow UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.